Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 3—March 2012
Dispatch

Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008

Xiaomeng Wang, Qian Fu, Zhijun Li, Songhua Chen, Zhengwei Liu, Hugh Nelson, Qun Yang, Zhongwei JiaComments to Author , and Christopher Dye
Author affiliations: Center for TB Control in Zhejiang, Hangzhou, People’s Republic of China (X. Wang, S. Chen, Z. Liu); Capital Medical University, Beijing, People’s Republic of China (Q. Fu, Q. Yang); National Research Institute of Food and Fermentation Industries, Beijing (Z. Li); International SOS Clinic, Shekou, People’s Republic of China (H. Nelson); Peking University, Beijing (Z. Jia); World Health Organization, Geneva, Switzerland (C. Dye)

Main Article

Table 1

Resistance to 2 TB drugs, by patient age, sex, and treatment status in Zhejiang Province, China, 1999, 2004, and 2008*

Year, group No. (%) patients
Total Isoniazid Rifampin MDR
1999
    Total 1,013 138 (13.6) 116 (11.5) 87 (8.6)
    Patients 0–14 years of age 12 (1.2) 1 (8.3) 1 (8.3) 1 (8.3)
    Patients 15–64 year of age 808 (79.8) 120 (14.9) 97 (12.0) 78 (9.7)
    Patients >65 years of age 193 (19.1) 17 (8.8) 17 (8.8) 8 (4.2)
    Male patients 723 (71.4) 100 (13.8) 81 (11.2) 60 (8.3)
    Female patients 290 (28.6) 38 (13.1) 35 (12.1) 27 (9.3)
    New cases 841 (83.0) 72 (8.6) 51 (6.1) 35 (4.2)
    Re-treatment cases 172 (16.9) 66 (38.4) 65 (37.8) 52 (30.2)
2004
    Total 984 159 (16.2) 94 (9.6) 75 (7.6)
    Patients 0–14 years of age 3 (0.3) 1 (33.3) 1 (33.3) 1 (33.3)
    Patients 5–64 years of age 764 (77.6) 125 (16.4) 74 (9.7) 58 (7.6)
    Patients >65 years of age 217 (22.1) 33 (15.2) 19 (8.8) 16 (7.4)
    Male patients 730 (74.2) 125 (17.1) 73 (10.0) 61 (8.4)
    Female patients 254 (25.8) 34 (13.4) 21 (8.3) 14 (5.5)
    New cases 831 (84.5) 102 (12.3) 41 (4.9) 30 (3.6)
    Re-treatment cases 153 (15.6) 57 (37.3) 53 (34.6) 45 (29.4)
2008
    Total 938 125 (13.3) 75 (8.0) 56 (6.0)
    Patients 0–14 years of age 5 (0.5) 0 1 (20.0) 0
    Patients 15–64 years of age 756 (80.6) 103 (13.6) 63 (8.3) 48 (6.4)
    Patients >65 years of age 177 (18.9) 22 (12.4) 11 (6.2) 8 (4.5)
    Male patients 646 (68.9) 91 (14.1) 55 (8.5) 40 (6.2)
    Female patients 292 (31.1) 34 (11.6) 20 (6.9) 16 (5.5)
    New cases 842 (89.8) 88 (10.5) 43 (5.1) 28 (3.3)
    Re-treatment cases 96 (10.2) 37 (38.5) 32 (33.3) 28 (29.2)

*TB, tuberculosis; MDR, multidrug resistant.

Main Article

Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external